Delivery Order SPE2DB20D3103-SPE2DB22FN0P9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $142,405.50 firm fixed-price delivery order is for the provision of VARIVAX vaccine with diluents. The contract has an ultimate completion date of March 5, 2024 and was awarded on February 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, worth $1,898.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, with a completion date of March 5, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award, valued at $4,705.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, a critical pharmaceutical product used for infectious disease prevention. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,942.72 for the supply of the VARIVAX vaccine with diluents. The contract was awarded by the Defense Logistics Agency (DLA) on April 4, 2022, with an ultimate completion date of April 25, 2022. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $1,599.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX vaccine with diluents, a critical medical commodity for the Department of Defense and other federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that has established itself as a key vendor...
- This federal contract award, valued at $79,995.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the VARIVAX vaccine with diluents, a critical medical product used for infectious disease prevention. The contract has a completion date of December 12, 2022 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has...
- This federal contract award, valued at $65,879.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, with a performance period ending on May 11, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $7,594.96 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the supply of VARIVAX vaccines with diluents. The award has an ultimate completion date of February 29, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for the delivery of VARIVAX vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,874.02 firm fixed-price delivery order contract has a completion date of May 20, 2024. This award is not designated as a set-aside contract. Cencora, Inc., doing business as Amerisourcebergen, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, valued at $3,885.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of VARIVAX vaccine with diluents, a critical pharmaceutical product for infectious disease prevention. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 18, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN0P9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,556,669,635 units of VARIVAX vaccine with diluents. The $116,563.20 firm-fixed-price contract has an ultimate completion date of April 8, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.6k | 3/18/22 |